BioCryst Pharmaceuticals BCRX
$7.22 −$0.10 (-1.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.10 -1.66%
Open$7.26
Prev close$7.32
Day range$7.15 – $7.39
Volume3.85M
Market cap$1.86B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts6
Average target$17.00+135.5% vs. price
- Buy 67%
- Hold 33%
Low $11.00Now $7.22Avg $17.00High $30.00
Recent rating changes
The last 20 actions on file set price targets from $11.00 to $32.00, averaging $18.15.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Nov 2026 | Wedbush | BUY | $17.00 |
| 4 Nov 2026 | RBC Capital | HOLD | $11.00 |
| 21 Oct 2026 | TD Cowen | BUY | $30.00 |
| 9 Oct 2026 | BofA Securities | BUY | $15.00 |
| 8 Oct 2026 | RBC Capital | HOLD | $11.00 |
| 30 Sep 2026 | J.P. Morgan | HOLD | $13.00 |
| 10 Sep 2026 | RBC Capital | HOLD | $11.00 |
| 8 Sep 2026 | Needham | BUY | $16.00 |
| 6 Aug 2026 | Wedbush | BUY | $20.00 |
| 6 Aug 2026 | H.C. Wainwright | BUY | $32.00 |
| 5 Aug 2026 | TD Cowen | BUY | $30.00 |
| 5 Aug 2026 | Needham | BUY | $16.00 |
| 5 Aug 2026 | RBC Capital | BUY | $13.00 |
| 15 Jul 2026 | BofA Securities | BUY | $15.00 |
| 13 Jul 2026 | Wedbush | BUY | $21.00 |
| 13 Jul 2026 | J.P. Morgan | HOLD | $12.00 |
| 7 Jul 2026 | RBC Capital | BUY | $14.00 |
| 30 Jun 2026 | Cantor Fitzgerald | BUY | $29.00 |
| 30 Jun 2026 | Wedbush | BUY | $21.00 |
| 30 Jun 2026 | Needham | BUY | $16.00 |
No comments yet — be the first to weigh in on BCRX.
Sign in to join the discussion.